-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2018 to Q2 2024.
- BioXcel Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -134 %, a 27.2% decline year-over-year.
- BioXcel Therapeutics, Inc. annual Return On Assets for 2023 was -145 %, a 98.8% decline from 2022.
- BioXcel Therapeutics, Inc. annual Return On Assets for 2022 was -72.9 %, a 67.3% decline from 2021.
- BioXcel Therapeutics, Inc. annual Return On Assets for 2021 was -43.5 %, a 18.5% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)